Deepcell Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$14.8M
- Investors
-
17
Deepcell General Information
Description
Developer of a microfluidic imaging platform designed to offer non-invasive genetic tests with diagnostic-level accuracy. The company's platform utilizes artificial intelligence to classify cells based on detailed visual features and isolate viable cells based on morphological distinctions, enabling researchers to eliminate the need for invasive diagnostic tests.
Contact Information
Website
www.deepcell.comCorporate Office
- 1360 O Brien Drive
- Menlo Park, CA 94025
- United States
Corporate Office
- 1360 O Brien Drive
- Menlo Park, CA 94025
- United States
Deepcell Timeline
Deepcell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 10-Aug-2026 | $14.8M | Completed | Generating Revenue | ||
| 5. Later Stage VC | 24-Apr-2025 | Cancelled | Generating Revenue | |||
| 4. Later Stage VC | 24-Apr-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 17-Mar-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 06-Sep-2019 | $20M | $25M | Completed | Startup | |
| 1. Seed Round | 27-Dec-2017 | $5M | $5M | Completed | Startup |
Deepcell Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-1 | ||||||||
| Series A | 924,193 | $0.000100 | 6% | $18.39 | $18.39 | 1x | $18.39 | 14.87% |
| Seed | 532,164 | $0.000100 | 6% | $9.4 | $9.4 | 1x | $9.4 | 8.56% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Deepcell Comparisons
Industry
Financing
Details
Deepcell Competitors (4)
One of Deepcell’s 4 competitors is Immunai, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immunai | Venture Capital-Backed | New York, NY | ||||
| ThinkCyte | Venture Capital-Backed | Tokyo, Japan | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Egenesis | Venture Capital-Backed | Cambridge, MA |
Deepcell Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Deepcell Patents
Deepcell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025184321-A1 | Systems and methods for cell classification in visualization space and sorting thereof | Pending | 29-Feb-2024 | ||
| US-20250218201-A1 | Analyzing phenotypes of cells | Pending | 29-Dec-2023 | ||
| US-20250191680-A1 | Analyzing cell phenotypes | Pending | 08-Dec-2023 | ||
| WO-2025122842-A1 | Analyzing cell phenotypes | Inactive | 08-Dec-2023 | ||
| WO-2025096338-A1 | Systems and methods for morphometric analysis | Inactive | 30-Oct-2023 | G06N3/045 |
Deepcell Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Deepcell Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Shunxi Private Equity Fund Management | Growth/Expansion | Minority | ||
| Casstar | Corporation | Minority | ||
| Cenova Capital | Venture Capital | Minority | ||
| Topview Innovation | Venture Capital | Minority | ||
| Tsinghua Innovation Ventures | Venture Capital | Minority |
Deepcell FAQs
-
When was Deepcell founded?
Deepcell was founded in 2015.
-
Where is Deepcell headquartered?
Deepcell is headquartered in Menlo Park, CA.
-
What is the size of Deepcell?
Deepcell has 32 total employees.
-
What industry is Deepcell in?
Deepcell’s primary industry is Discovery Tools (Healthcare).
-
Is Deepcell a private or public company?
Deepcell is a Private company.
-
What is Deepcell’s current revenue?
The current revenue for Deepcell is .
-
How much funding has Deepcell raised over time?
Deepcell has raised $113M.
-
Who are Deepcell’s investors?
Beijing Shunxi Private Equity Fund Management, Casstar, Cenova Capital, Topview Innovation, and Tsinghua Innovation Ventures are 5 of 17 investors who have invested in Deepcell.
-
Who are Deepcell’s competitors?
Immunai, ThinkCyte, Illumina, and Egenesis are competitors of Deepcell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
